DiaSorin S p A : Half-Year Financial Report at June 30, 2022

HALF-YEAR FINANCIAL REPORT

JUNE 30, 2022

DiaSorin S.p.A.

Via Crescentino (no building No.) - 13040 Saluggia (VC) Tax I.D. and Vercelli Company Register n. 13144290155

Contents
DIASORIN'S WORLD
1. BOARD OF DIRECTORS & CONTROL BODIES	..................................................................................... 3
2. DIASORIN WORLDWIDE ....................................................................................................................	4
3. THE DIASORIN GROUP ......................................................................................................................	5
4. OUR BUSINESS ..................................................................................................................................	6
GROUP'S TECHNOLOGIES
1. IMMUNODIAGNOSTICS .......................................................................................................................	7
2. MOLECULAR DIAGNOSTICS ...............................................................................................................	7
3. LICENSED TECHNOLOGIES.................................................................................................................	9
4. RESEARCH AND DEVELOPMENT ......................................................................................................	10
OVERVIEW OF THE RESULTS
1 CONSOLIDATED FINANCIAL HIGHLIGHTS ..........................................................................................	11

2. OVERVIEW OF THE GROUP'S PERFORMANCE IN THE FIRST HALF OF 2022 AND COMPARISON WITH

2021................................................................................................................................................	12
3. REVIEW OF THE GROUP'S OPERATING PERFORMANCE AND FINANCIAL POSITION .............................	15
4. STATEMENT OF FINANCIAL POSITION OF THE GROUP AT JUNE 30, 2022 ..........................................	20
5. TRANSACTIONS RESULTING FROM NON-RECURRING, ATYPICAL AND/OR UNUSUAL OPERATIONS.....	23
6. MAIN RISKS AND UNCERTAINTIES TO WHICH DIASORIN S.P.A. AND THE GROUP ARE EXPOSED ......	24
7. SIGNIFICANT EVENTS OCCURRED AFTER JUNE 30, 2022 AND BUSINESS OUTLOOK...........................	26
8. RELATED-PARTYTRANSACTIONS ....................................................................................................	27

CONDENSED HALF-YEAR CONSOLIDATED FINANCIAL STATEMENTS AT JUNE 30, 2022

1.	CONSOLIDATED INCOME STATEMENT..............................................................................................	28
2.	CONSOLIDATED COMPREHENSIVE INCOME STATEMENT ..................................................................	29
3.	CONSOLIDATED STATEMENT OF FINANCIAL POSITION .....................................................................	30
4.	CONSOLIDATED STATEMENT OF CASH FLOWS .................................................................................	32
5.	STATEMENT OF CHANGES IN CONSOLIDATED SHAREHOLDERS' EQUITY ...........................................	33
6.	NOTES TO THE CONDENSED HALF-YEAR CONSOLIDATED FINANCIAL STATEMENTS .........................	35
7.	ANNEX I: THE COMPANIES OF THE DIASORIN GROUP AT JUNE 30, 2022.........................................	63
8.	CERTIFICATION OF THE CONDENSED HALF-YEAR CONSOLIDATED FINANCIAL STATEMENTS ............	64

REPORT ON OPERATIONS

DIASORIN'S WORLD

1. BOARD OF DIRECTORS & CONTROL BODIES

BOARD OF DIRECTORS (appointed on April 24, 2019)

Chairman	Michele Denegri
Deputy Chairman	Giancarlo Boschetti
Chief Executive Officer	Carlo Rosa (1)
Directors	Chen Menachem Even
	Stefano Altara
	Fiorella Altruda (2)
	André Michel Ballester (2) (3)
	Luca Melindo
	Franco Moscetti
	Giovanna Pacchiana Parravicini (2)
	Francesca Pasinelli (2)
	Diego Pistone
	Roberta Somati (2)
	Monica Tardivo (2)
	Tullia Todros (2)
BOARD OF STATUTORY AUDITORS
Chairman	Monica Mannino
Statutory Auditors	Ottavia Alfano
	Matteo Michele Sutera
Alternates	Romina Guglielmetti
	Cristian Tundo
INDEPENDENT AUDITORS	PricewaterhouseCoopers S.p.A.
COMMITTEES
Control, Risk and Sustainability	André Michel Ballester (Chairman)
Committee	Franco Moscetti
	Roberta Somati
Compensation and Nominating	Roberta Somati (Chairman)
Committee	Giancarlo Boschetti
	Giovanna Pacchiana Parravicini
Related-Party Committee	Roberta Somati (Chairman)
	André Michel Ballester
	Giovanna Pacchiana Parravicini
(1) General Manager
(2) Independent Director
(3) Lead Independent Director

2. DIASORIN WORLDWIDE

3. THE DIASORIN GROUP